Open AccessIrreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma
Author(s) -
Kai Xu,
Yongliang Chen,
Jun-Jun Su,
Ming Su,
Yan Li
Publication year - 2020
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_773_18
Subject(s) - medicine , irreversible electroporation , chemoradiotherapy , radiation therapy , positron emission tomography , context (archaeology) , magnetic resonance imaging , carcinoma , chemotherapy , survival rate , adjuvant , radiology , oncology , electroporation , nuclear medicine , paleontology , biochemistry , chemistry , biology , gene
The safety and efficacy of irreversible electroporation (IRE) for locally advanced pancreatic carcinoma (LAPC) are well established. However, whether adjuvant chemoradiotherapy after IRE increases, the survival rate remains unknown. Therefore, this study evaluated the effect of chemoradiotherapy combined with IRE in patients with LAPC.